Perspectives for the treatment of brucellosis in the 21st century: the ioanninarecommendations
- Autori: Ariza, J.; Bosilkovski, M.; Cascio, A.; Colmenero, J.; Corbel, M.; Falagas, M.; Memish, ; Za, ; Roushan, M.; Rubinstein, E.; Sipsas, N.; Solera, J.; Young, E.; Pappas, G.
- Anno di pubblicazione: 2007
- Tipologia: Articolo in rivista
- OA Link: http://hdl.handle.net/10447/381309
Brucellosis remains the commonest anthropozoonosis worldwide, and its treatment remains complex, requiring protracted administration of more than one antibiotic. • In November 2006, a consensus meeting aimed at reaching a common specialist statement on the treatment of brucellosis was held in Ioannina, Greece under the auspices of the International Society of Chemotherapy and the Institute of Continuing Medical Education of Ioannina. • The author panel suggests that the optimal treatment of uncomplicated brucellosis should be based on a six-week regimen of doxycycline combined either with streptomycin for 2–3 weeks, or rifampicin for six weeks. Gentamicin may be considered an acceptable alternative to streptomycin, while all other regimens/combinations should be considered second-line. • The development of a common global therapeutic language for human brucellosis, and future, properly conducted clinical trials would definitely solve controversies regarding the disease.